Home
At a glance
Contact us
About us
Debiopharm Group
Debiopharm International SA
Debiopharm Research & Manufacturing SA
Debiopharm Investment SA
Debiopharm Diagnostics SA
At a glance
Welcome
Mission & Values
History
Our business
Business Model
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Personalized Medicine
Expertise
Preclinical
Clinical
Innovative drug delivery and formulation
Manufacturing
Regulatory
Products
Eloxatin®/Elpat®
Decapeptyl® + Trelstar®/Pamorelin®
Moapar®/Salvacyl®
Responsibility
Scientific Awards
Environment
Entrepreneurship
Patronage
Sarah Marquis
Dialogue Généractions
Charities
Kantuta
Les Pinceaux Magiques
Careers
Media
Press Releases
Publications
Download center
Events
Corporate Film
Debiopharm Group
More...
Debiopharm International SA
More...
Debiopharm Research & Manufacturing SA
More...
Debiopharm Investment SA
More...
Debiopharm Investment SA
More...
«
»
01
Debiopharm Group
02
Debiopharm International SA
03
Debiopharm Research & Manufacturing SA
04
Debiopharm Investment SA
05
Debiopharm Investment SA
Pause
Let's meet
October 2-3
Debiopharm Group will be delighted to meet you at
BioContact Quebec
in Canada.
ALL EVENTS
Discover our corporate film
Latest news
Aurigene and Debiopharm Group™ report nomination of development candidate Debio 0617B in oncology
Diagnoplex S.A. closes a financing round led by Debiopharm Group™
Debiopharm Group™ announces additional phase I clinical trial evaluating Debio 1143 combined with chemotherapies for patients with selected solid malignancies
Financement de Bourses d’excellence Debiopharm à l’EPFL et création de la 'Debiopharm academy'
Wednesday, 19 June 2013
Aurigene and Debiopharm Group™ report nomination of development candidate Debio 0617B in oncology
Friday, 07 June 2013
Diagnoplex S.A. closes a financing round led by Debiopharm Group™
Tuesday, 04 June 2013
Debiopharm Group™ announces additional phase I clinical trial evaluating Debio 1143 combined with chemotherapies for patients with selected solid malignancies
Thursday, 30 May 2013
Financement de Bourses d’excellence Debiopharm à l’EPFL et création de la 'Debiopharm academy'
ALL NEWS
Follow our latest
Products Pipeline
Debiopharm Group
presented
at a glance
Social & Corporate
Responsibility
© 2013 Debiopharm Group™
Legal Notice
Terms&Conditions
CSOnline
Credits
Sitemap
